Quantum-Enhanced Classification of Brain Tumors Using DNA Microarray Gene Expression Profiles

Emine Akpinar, Batuhan Hangun, Murat Oduncuoglu, Oguz Altun, Onder Eyecioglu, Zeynel Yalcin · 2025

Read Quantum-Enhanced Classification of Brain Tumors Using DNA Microarray Gene Expression Profiles by Emine Akpinar, Batuhan Hangun, Murat Oduncuoglu, Oguz Altun, Onder Eyecioglu, Zeynel Yalcin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2505-02033.txt.

Introduction

Emine Akpinar and co-authors classify brain tumors with a quantum classifier fed by gene data. Their 2025 paper uses DNA microarray profiles, which read the activity of tens of thousands of genes at once, a rich but unwieldy input for standard machine learning.

The team proposes Deep VQC, a variational quantum classifier meant to exploit quantum parallelism for such high-dimensional data. Trained on a set with more than fifty-four thousand gene features, it sorted four tumor types, from glioblastoma to pilocytic astrocytoma, plus healthy samples with high accuracy. Its scores matched or beat classic algorithms in the study. The authors present quantum AI as a promising route for reading complex disease signatures.

Catalog record

CREATOREmine Akpinar, Batuhan Hangun, Murat Oduncuoglu, Oguz Altun, Onder Eyecioglu, Zeynel Yalcin
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2505-02033

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Quantum-Enhanced Classification of Brain Tumors Using DNA Microarray Gene Expression Profiles Emine Akpinar, Batuhan Hangun, Murat Oduncuoglu, Oguz Altun, Onder Eyecioglu, Zeynel Yalcin Abstract DNA microarray technology enables the simultaneous measurement of expression levels of thousands of genes, thereby facilitating the understanding of the molecular mechanisms underlying complex diseases such as brain tumors and the identification of diagnostic genetic signatures. To derive meaningful biological insights from the high-dimensional and complex gene features obtained through this technology and to analyze gene properties in detail, classical artificial intelligence (AI)-based approaches such as machine learning (ML) and deep learning (DL) are widely employed. However, these methods face various limitations in managing high-dimensional vector spaces and modeling the intricate relationships among genes. In particular, challenges such as hyperparameter tuning, computational costs, and high processing power requirements can hinder their efficiency. To overcome these limitations, quantum computing and quantum AI approaches are gaining increasing attention. Leveraging quantum properties such as superposition and entanglement, quantum methods enable more efficient parallel processing of high-dimensional data and offer faster and more effective solutions to problems that are computationally demanding for classical methods. In this study, a novel model called “Deep VQC” is proposed, based on the Variational Quantum Classifier (VQC) approach. Developed using microarray data containing 54,676 gene features, the model successfully classified four different types of brain tumors—ependymoma, glioblastoma, medulloblastoma, and pilocytic astrocytoma—alongside healthy samples with high accuracy. Furthermore, compared to classical ML algorithms, the Deep VQC model demonstrated either superior or comparable classification performance. These results highlight the potential of quantum AI methods as an effective and promising approach for the analysis and classification of complex structures such as brain tumors based on gene expression features. I Introduction Brain tumors, or intracranial neoplasms, arise as a result of the abnormal growth of cells within or around the brain, and they constitute one of the leading causes of increasing mortality rates across different age groups. When this tumor formation originates from the brain tissue itself, it is classified as primary; if it originates from another part of the body and represents a distant metastasis of a primary tumor, it is considered secondary. Accurate diagnosis and evaluation of these tumors are critically important for both treatment planning and prognosis. The diagnosis and grading of brain tumors largely rely on radiological findings and data derived from the histopathological characteristics of the tumors. In addition, technologies such as DNA microarrays enable the identification of gene expression profiles specific to brain tumors, thus allowing molecular-level classification and the development of more effective and precise treatment strategies [ 1 ] . DNA microarray (or simply microarray) is a molecular biology technique used to determine the overall gene expression profiles of various biological entities—such as organisms, tissues, or cells—and to perform mutation analysis. In other words, it is a method that simultaneously monitors the expression levels of thousands of genes in order to identify which genes are expressed or activated, and to what extent, under specific conditions [ 2 , 3 , 4 ] . This technique has accelerated the transition from gene-level research to genome-wide studies, making it possible to assess expression levels across the entire genome. Therefore, rather than analyzing individual genes to reveal gene expression patterns involved in complex biological processes such as tumor development, the ability to examine many—or even all—genes at once is crucial for understanding disease mechanisms and for developing more effective diagnostic and therapeutic strategies. While microarray technology offers significant advantages, it also involves a complex analytical process that presents several challenges. One of the primary challenges is the enormous volume of data generated by microarray experiments, often referred to as the high-dimensionality problem. For instance, a microarray experiment involving 15,000 genes related to a brain tumor yields data that can be represented as a 15,000-dimensional vector in a classical vector space. This high dimensionality poses substantial computational difficulties when analyzing such datasets. Another major challenge lies in extracting meaningful biological insights from this vast and complex microarray data [ 5 ] . Identifying gene features that may be critical for brain tumor classification and early diagnosis presents significant obstacles, both in terms of computational cost and data analysis. In addition to these challenges, microarray datasets typically contain a relatively small number of samples (or cases) while encompassing thousands of gene features. As a result, a vast amount of gene expression information is obtained from each individual case. This imbalance is known in data science as the ”curse of dimensionality” and represents one of the most significant challenges when working with microarray data [ 6 , 7 ] . To address these challenges and effectively analyze the large-scale data generated by microarray experiments, classical artificial intelligence (AI) approaches—particularly machine learning (ML) and deep learning (DL)—have been increasingly employed in recent years. Through these methods, microarray data can be analyzed to extract and interpret meaningful features or patterns. In ML-based approaches, gene expression profiles—represented as high-dimensional vectors—can be processed using feature selection techniques to identify the most relevant and informative gene features, thereby reducing both data dimensionality and computational cost. Moreover, ML algorithms can be trained on the selected features to classify new samples through supervised learning. In DL approaches, which rely on hierarchical feature learning, features are automatically extracted from raw data, enabling the learning of high-level representations directly from microarray inputs. In the literature, both ML and DL methods have been successfully applied to various tasks involving microarray data, including tumor and cancer classification [ 8 , 9 ] , biomarker discovery [ 10 ] , and understanding disease mechanisms [ 10 ] . However, despite their promising performance in selecting key gene features and classifying complex diseases such as brain tumors, these methods face certain limitations. Specifically, they are affected by high-dimensional data structures involving thousands of gene features, complex relationships between features, the dimensionality of the classical vector space, and the need for careful hyperparameter tuning. Furthermore, as data volume increases, these methods tend to require significantly higher computational resources. Recent studies have shown that in order to overcome data- and computation-based challenges and to address complex problems such as brain tumor classification based on gene features, there is a growing need for quantum computing and quantum computing-based AI techniques. Quantum computing refers to the development of computational technologies grounded in the fundamental principles of quantum mechanics, aiming to address problems that exceed the capabilities of classical computational methods. This approach exploits quantum phenomena such as superposition, entanglement, and interference to achieve solutions where classical methods either fall short or become computationally infeasible [ 11 ] . In some cases, quantum algorithms can offer results comparable to classical ones, while in others they promise significantly higher processing capacity and computational speed. Moreover, this paradigm enables the processing, analysis, and transmission of information within a quantum framework. Quantum computing-based AI, on the other hand, seeks to harness the power of quantum computation in combination with classical AI algorithms to enhance performance in tasks such as pattern recognition, data processing, classification, and optimization. Currently, quantum computing and quantum computing-based AI methods are being explored in various applications, including microarray data analysis, gene selection, and the early diagnosis of brain tumors [ 12 , 13 ,

Read the complete text